Exploring anticancer activity of wild and polyploid mutant of Artemisia cina




Abstract. Kasmiyati S, Kristiani EBE, Herawati MM, Rondonuwu FS. 2021. Exploring anticancer activity of wild and polyploid mutant of Artemisia cina.  Biodiversitas 22: 1227-1234. The research aims were to explore the anticancer compounds in wild type (W) and polyploid mutant (P) of Artemisia cina Berg ex Poljakov using NIR and compare their cytotoxicity and selectivity on WiDR colon cancer and HTB183 lung cancer cell lines and Vero normal cell line. The W was obtained from B2P2TOOT Tawangmangu, Indonesia while P was by inducing A. cina shoot culture with 100 mg/l colchicine for 48 hours. They were extracted with hexane using the soxhletation method for 6 hours. The anticancer compounds were detected using NIR. The cytotoxic activity was determined using MTT assay, with Doxorubicin (D) as a control. The calculation of IC50 value used SPSS16 with a Probit analysis. The P contained the determined four compounds while the W contained no rutin. The IC50 values of W, P, and D were 295.5, 84.1, and 0.5 µg/mL on WiDr, 322.4, 128.6, and 39.9 µg/mL on HTB 183, whereas on Vero were 104, 315.6, and 295.5 µg/mL respectively. The selectivity indexes of W, P, and D were 34, 4, and 91 on WiDr, while HTB 183 was 31, 3, and 7, respectively. The P contained artemisinin, quercetin, kaemferol, and rutin, while the W contained no rutin. The cytotoxicity of both plants was less than doxorubicin. Both plants were selective on WiDR and HTB 183.


Abotaleb M, Samuel SM, Varghese E, et al., 2019. Flavonoids in cancer and apoptosis. Cancer, 11 : 1-39.
Akter R, Uddin, SJ. I. D. Grice et al., “Cytotoxic activity screening of Bangladeshi medicinal plant extracts,” Journal of Natural Medicine, vol. 68, pp. 246-252, 2014
Almehdar H, Abdallah H, Osman A-M. M, et al. 2012. In vitro cytotoxic screening of selected Saudi medicinal plants. Journal of Natural Medicine, 66 : 406–412.
Arullappan S, Muhamad S, Zakaria Z. 2013. Cytotoxic activity of the leaves and stem extracts of Hibiscus rosa sinensis (Malvaceae) against leukaemic cell line (K-562). Tropical Journal of Pharmaceutical Research. 12 : 743-746, 2013.
Badisa RB, Ayuk-Takem LT, Ikediobi CO et al. 2006. Selective Anticancer Activity of Pure Licamichauxiioic-B Acid in Cultured Cell Lines. Pharmaceutical Biology. 44 : 141–145.
Baikar S and Malpathak. 2010. Secondary metabolites as DNA topoisomearse inhibition: a new era toward designed of anticancer drugs. Pharmacognosy Review. 4 : 12-26.
Crespo-Ortiz MP, and Wei MQ. 2012. Antitumor Activity of Artemisinin and Its Derivatives: From a Well-Known Antimalarial Agent to a Potential Anticancer Drug. Journal of Biomedicine and Biotechnology. 2012 : 1-18.
Croteau R, Kutchen TM, Lewis NG. 2000. Natural Product (Secondary Metabolites). In: Buchanan B, Gruissem W, Jones R., (eds) Biochemistry and Molecular Biology of Plants. American Society of Plant Physiologists.
Dixit. 2014. Anticancer Effect of Rutin Isolated from the Methanolic Extract of Triticum aestivum Straw in Mice. Medical Science. 2 : 153-160.
Greenwell M and Rahman PKSM. 2015. Medicinal Plants: Their Use in Anticancer Treatment. International Journal of Pharmaceutical Sciences and Research, 6 : 4103–4112.
Herawati MM, Pudjihartati E, Pramono S, et al. 2015. Obtaining Artemisia cina Polyploid Trhough Plant Growth Regulator Treatment in Shoot Culture. Agrivita. 37 : 178–184.
Ibrahem NM. 2017. Extraction & Characterization of Iraqi Artemisia dracunculus dried aerial parts extract thought HPLC and GC-MS analysis with evaluation of its antitumor activity against 7, 12-dimethylbenze (a) anthracene induced skin cancer in mice. International Journal of Pharmacy and Pharrmaceutical Science. 9 : 34-42.
Kashani HH, Hoseini ES, Nikzad, et al., 2012. Pharmacological properties of medicinal herbs by focus on secondary metabolites. Life Science Journal. 9 : 509-520.
Koul B, Taak P, Kumar A. et al. 2017. The Artemisia Genus: A Review on Traditional Uses, Phytochemical Constituents, Pharmacological Properties and Germplasm Conservation. Journal of Glycomics & Lipidomics JGL. 7 : 142-148.
Kursat M, Emre I, Yilmaz O et al. 2015. Phytochemical. Contents of Five Artemisia Species. Notulae Scientia Biologicae, 7 : 495-499.
Kopustinskiene DM, Jakstas V, Savickas A, et al. 2020. Flavonoids as Anticancer Agents. Nutrients, 12 : 457-480.
Lee S, Peterson CJ, Coats JR. 2003. Fumigation toxicity of monoterpenoids to several stored product insects. J. Stored Prod Res. 39 : 77–85.
Mannan A, Ahmed I, Arshad W et al. 2010. Survey of Artemisinin Production by Diverse Artemisia Species in Northern Pakistan. Malaria Journal 9 : 310-318.
Panche AN, Diwan AD, Chandra SR. 2016. Flavonoids: an overview. Journal of Nutritional Science. 5 : 1-15.
Yuan H, Lu X, Ma Q et al. 2016. Flavonoids from Artemisia sacrorum Ledeb. and their cytotoxic activities against human cancer cell lines,” Experimental and Therapeutic Medicine. 12 : 1873-1878.
Zhu XX, Yang L, Li Y et al. 2013. Effects of sesquiterpene, flavonoid and coumarin types of compounds from Artemisia annua L. on production of mediators of angiogenesis. Pharmacological Reports. 65 : 410-420.